Follow-up procedures for non-muscle-invasive bladder cancer: an update

被引:0
作者
Anastasiadis, Anastasios [1 ]
Cordeiro, Ernesto [1 ]
Bus, Mieke T. J. [1 ]
Alivizatos, Gerasimos [2 ]
de la Rosette, Jean J. M. C. H. [1 ]
de Reijke, Theo M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Hygeia Hosp, Athens, Greece
关键词
bladder neoplasm; cystoscopy; individualization; surveillance; ultrasonography; urine cytology; urine marker; TRANSITIONAL-CELL-CARCINOMA; BACILLUS-CALMETTE-GUERIN; IN-SITU HYBRIDIZATION; VOIDED-URINE SAMPLES; MATRIX PROTEIN 22; UROTHELIAL CARCINOMA; MICROSATELLITE ANALYSIS; DIAGNOSTIC-ACCURACY; FLEXIBLE CYSTOSCOPY; PROGNOSTIC-FACTORS;
D O I
10.1586/ERA.12.98
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bladder carcinoma is the most common malignancy of the urinary tract. Approximately 75-85% of patients present with a disease that is confined to the mucosa (stage Ta, carcinoma in situ) or submucosa (stage T1). The stratification of patients to low-, intermediate- and high-risk groups represents the cornerstone for the indication of adjuvant and follow-up treatment. Owing to the high recurrence rate of bladder tumors, a surveillance protocol is recommended to all patients. Currently, the combination of cystoscopy, imaging and urinary cytology represent the follow-up. A systematic review of the recent English literature on follow-up procedures of non-muscle-invasive bladder cancer is performed. The authors review the existing follow-up procedures, with a focus on novel molecular-targeted approaches. At the present time, the additional use and utility of urine-based molecular markers in the follow-up of patients remains unclear and we have to rely on cystoscopic evaluation adapted to risk group classification.
引用
收藏
页码:1229 / 1241
页数:13
相关论文
共 92 条
[51]   Primary superficial bladder cancer risk groups according to progression, mortality and recurrence [J].
Millán-Rodríguez, F ;
Chéchile-Toniolo, G ;
Salvador-Bayarri, J ;
Palou, J ;
Algaba, F ;
Vicente-Rodríguez, J .
JOURNAL OF UROLOGY, 2000, 164 (03) :680-684
[52]   Upper urinary tract tumors after primary superficial bladder tumors:: Prognostic factors and risk groups [J].
Millán-Rodríguez, F ;
Chéchile-Toniolo, G ;
Salvador-Bayarri, J ;
Huguet-Pérez, J ;
Vicente-Rodríguez, J .
JOURNAL OF UROLOGY, 2000, 164 (04) :1183-1187
[53]   Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria [J].
Miyanaga, N ;
Akaza, H ;
Tsukamoto, T ;
Ishikawa, S ;
Noguchi, R ;
Ohtani, M ;
Kawabe, K ;
Kubota, Y ;
Fujita, K ;
Obata, K ;
Hirao, Y ;
Kotake, T ;
Ohmori, H ;
Kumazawa, J ;
Koiso, K .
INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (04) :173-177
[54]   UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer [J].
Moonen, Paula M. J. ;
Merkx, Gerard F. M. ;
Peelen, Pim ;
Karthaus, Herbert F. M. ;
Smeets, Dominique F. C. M. ;
Witjes, J. Alfred .
EUROPEAN UROLOGY, 2007, 51 (05) :1275-1280
[55]   FUTURE PROSPECTS FOR BLADDER CANCER BIOMARKERS [J].
Mukhtar, Saheel ;
Perry, Matthew J. A. .
BJU INTERNATIONAL, 2011, 108 (10) :1541-1543
[56]   Management of stage T1 tumors of the bladder: International consensus panel [J].
Nieder, AM ;
Brausi, M ;
Lamm, D ;
O'Donnell, M ;
Tomita, K ;
Woo, H ;
Jewett, MAS .
UROLOGY, 2005, 66 (6A) :108-125
[57]  
Nisman B, 2009, ANTICANCER RES, V29, P4281
[58]  
Olsson H, 2001, SCAND J UROL NEPHROL, V35, P280
[59]   The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer [J].
Otto, Wolfgang ;
Denzinger, Stefan ;
Fritsche, Hans-Martin ;
Burger, Maximilian ;
Wieland, Wolf F. ;
Hofstaedter, Ferdinand ;
Hartmann, Arndt ;
Bertz, Simone .
BJU INTERNATIONAL, 2011, 107 (03) :404-408
[60]   Prognostic Significance of the 2004 WHO/ISUP Classification for Prediction of Recurrence, Progression, and Cancer-Specific Mortality of Non-Muscle-Invasive Urothelial Tumors of the Urinary Bladder [J].
Pan, Chin-Chen ;
Chang, Yen-Hwa ;
Chen, Kuang-Kuo ;
Yu, Hui-Jung ;
Sun, Chih-Hao ;
Ho, Donald M. T. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (05) :788-795